Operational Updates. The reports shall provide sufficient information to document key operational and other challenges, underlying causes of challenges, how challenges are being addressed, as well as key achievements and to what conditions and efforts successes can be attributed. The discussion should also include any lawsuits or legal actions; unusual or unanticipated trends; legislative updates; and descriptions of any public forums held.
Operational Updates. Per 42 CFR §431.428, the Annual Monitoring Report must document any policy or administrative difficulties in operating the demonstration. The reports shall provide sufficient information to document key challenges, underlying causes of challenges, how challenges are being addressed, as well as key achievements and to what conditions and efforts successes can be attributed. The discussion should also include any issues or complaints identified by beneficiaries; lawsuits or legal actions; unusual or unanticipated trends; legislative updates; descriptions of any public forums held, and a summary of program integrity and related audit activities for the demonstration. The Annual Monitoring Report should also include a summary of all public comments received through the post-award public forum required per 42 CFR §431.420(c) regarding the progress of the demonstration.
Operational Updates. The LOI is currently in its early stages and no specific terms (such as consideration to be paid to Elephant Extracts) have been agreed upon. However, the company has indicated in the associated press release that Elephant Extracts will reserve the right to redeem RavenQuest’s majority interest at such a time that Elephant Extracts receives an ACMPR license to produce. If exercised, the controlling interest of RavenQuest will be removed and RavenQuest will receive a 15% royalty on the gross revenue from Elephant Extract’s production facility in perpetuity. The practicality of execution of this addendum is uncertain and it may not be featured in the final agreement between the two parties. On June 6, 2018, the company announced that it had entered into a binding LOI with WAL and 0929476 B.C. Ltd. (“NumberCo”) to acquire WAL, and a 15-acre land package held by NumberCo. The binding LOI comes as an advancement of a previous MOU between RavenQuest and WAL. WAL is a late-stage ACMPR applicant that is developing a 125,000 square-foot production facility in Port Mellon, B.C. We assume that the 15-acre land package held by NumberCo is the land upon which the WAL facility will be built. XXX also owns 23.75% of Atlantic Cannabis Corp., which intends to build a 50,000 square-foot facility in Nova Scotia. Terms under the binding LOI include all stock consideration to WAL of 4.34 million shares of RavenQuest at a deemed price of $0.85 per share, valuing the transaction at $3.68 million. This is lower than our estimate of $4.40 million, which we had provided in our most recent note on the company, which covered the WAL acquisition. Our CAPEX estimate for the WAL facility is $35.21 million. This is based on a blended CAPEX per-square foot of $282, which is an average of the initial and expansion build-out costs exhibited by the company’s AGB and Bloomera facilities. The CAPEX table for the company’s current projects is as below. Note that the minority interest in Atlantic Cannabis Corp., which intends to build-out a facility in Nova Scotia, is not included in our models as we do not have sufficient details. $ 29,000,000 $ 8,839,437 $ 40,940,845 $ 5,729,577 Bloomera AGB Fort XxXxxxxx (30%) WAL $ $ $ $ - - 5,729,577 - In a historic milestone on June 19, 2018, the Canadian government moved to legalize cannabis for recreational use with the passing of Bill C-45, with an expected launch date of October 17, 2018. With uncertainty regarding the possibility of cannabis legalizat...
Operational Updates. Prior to the earlier to occur of the Closing and the termination of this Agreement in accordance with Article 10, upon reasonable advance written notice from Buyer to Seller, Seller shall make itself available during normal business hours to confer with one or more Representatives of Buyer to (i) report operational matters of materiality affecting the Business and the general status of ongoing operations of the Business and (ii) discuss (and in good faith assist Buyer in formulating) Buyer’s plans for conducting the combined operations of Buyer and its Affiliates, together with the Business, after the Closing.
Operational Updates. The executive officers of the Company and the Bank agree to meet with senior officers of Parent as reasonably requested by Parent to review the financial and operational affairs of the Bank, and to the extent permitted by applicable Law, each of the Company and the Bank agrees to give reasonable consideration to Parent’s input on such matters, consistent with this Section 5.18, with the understanding that Parent shall in no event be permitted to exercise control of the Company or the Bank prior to the Effective Time and, except as specifically provided under this Agreement, the Company and the Bank shall have no obligation to act in accordance with Parent’s input.
Operational Updates. The executive officers of the Company agree to meet with senior officers of Parent as reasonably requested by Parent to review the financial and operational affairs of the Company.
Operational Updates. Vendor shall, until the earlier of the Closing Time or the termination of this Agreement, provide weekly updates of operations in respect of the Assets and, subject to any applicable confidentiality obligations in favour of Third Parties, will discuss all operational decisions with Purchaser relating to the Assets.
Operational Updates. All operating information needed to effectuate the EDI processes defined in this agreement is outlined in the EDI Worksheet(s). Such information is subject to change, and each party shall communicate timely such changes to the counterparty.
Operational Updates. Per 42 CFR 431.428, the Monitoring Reports must document any policy or administrative difficulties in operating the demonstration. The reports shall provide sufficient information to document key challenges, underlying causes of challenges, how challenges are being addressed, as well as key achievements and to what conditions and efforts successes can be attributed. The discussion should also include any issues or complaints identified by beneficiaries; lawsuits or legal actions; unusual or unanticipated trends; legislative updates; and descriptions of any public forums held. The Monitoring Report should also include a summary of all public comments received through post- award public forums regarding the progress of the demonstration.
Operational Updates. 19 Efficiency Task Force The DHBs advised that the paper updates the existing Efficiency Register. Certified True copies The Ministry of Health (MoH) note that one action had not been incorporated into the paper and requested that it was captured in the minutes: There is a line item in the table that discussed certified true copies and whether non-pharmacists can carry out that process. MoH have undertaken to work with TAS to work through the Procedures Manual and identify if something is administrative or specifically states a pharmacist must do it. In these cases, MoH will convene a meeting with the right parties to identify whether there is a regulatory reason for it to be a pharmacist. If not, it is a procedural matter to shift it to gain efficiency. If it is, MoH will take it to the Therapeutics Products Bill (TPB) team to check if there is a way to identify if there is a real risk and if so, how this can shift the MoH system setting. It is anticipated that this could be completed within 12 months. It was agreed that providers try to get the best workflow management and right resources in the right place therefore they clearly have an interest in this discussion and it would be inappropriate to determine this without provider input. Prescription Quality Nirvana Pharmacy Group noted that the Efficiencies Register has an item under ‘General Practice, Practice Management System Requirements’ that the New Zealand electronic Prescription Service (NZePS) rolls out through the sector and there are some efficiencies but also some inefficiencies in this area. Prescription quality has not improved with NZePS. It would be good to get a focus on improving the data quality from all prescriptions including those that are transmitted through NZePS. It was noted that the proportion of prescriptions that are now electronic are up to 25% and this area should be made a priority. This matter will be referred to the Data and Digital team at the MoH. Manual claiming and reporting Manual Claiming and Reporting is growing as enhanced services expand - such as Medicines Use Reviews (MURs), Community Pharmacy Anticoagulation Service (CPAMs), Gout Services and influenza vaccinations. They all have a requirement for manual reporting and manual recording of data. It would be good to have electronic, rather than manual processes. A request was made for this to be added to the Efficiencies Register under submission of claims. DHBs agreed with the issues raised noting that there was...
